Dr. Michael Reedijk, a graduate of the Department of Microbiology and Immunology at McGill University, completed his Doctoral studies in signal transduction in the Department of Medical Genetics at the University of Toronto in 1993. Overlapping with his Ph.D. studies, Dr. Reedijk completed undergraduate training in Medicine (U of T), graduating in 1995. Dr. Reedijk began specialty training at the University of Toronto in General Surgery in 1996, and became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After completing combined clinical (Surgical Oncology) and post-doctoral research (Hospital for Sick Children – Division of Blood and Cancer) fellowships, Dr. Reedijk began his Surgical Oncology Staff Appointments at Mount Sinai Hospital and University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto. His clinical practice is devoted to the surgical treatment of melanoma and malignancies of the breast. In 2007 Dr. Reedijk was cross-appointed as an Assistant Professor in the Department of Medical Biophysics at the University of Toronto. His research lab is within The Campbell Family Institute for Breast Cancer Research/Ontario Cancer Institute at the Princess Margaret Hospital where his focus is on Notch Signaling in Breast Cancer. Dr. Reedijk was appointed as the Head of Research, Department of Surgical Oncology at the University Health Network and Mount Sinai Hospital in 2006.